Mangoceuticals, Inc.
Mangoceuticals, Inc. (MGRX) Stock Overview
Explore Mangoceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
18.4M
P/E Ratio
-0.71
EPS (TTM)
$-4.63
ROE
-0.73%
MGRX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Mangoceuticals, Inc. (MGRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 53.01, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.43.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.71 and a market capitalization of 18.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.